FCM
CRSP icon

Fortis Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Fortis Capital Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,914
Closed -$634K – 110
2021
Q2 		$634K Buy
+3,914
New +$634K 0.32% 82